Literature DB >> 8812681

Sarcoidosis: A Model of Granulomatous Inflammation of Unknown Etiology Associated with a Hyperactive Immune System

.   

Abstract

Sarcoidosis is a systemic granulomatous disorder of unknown etiology, characterized by hyperactive cellular and humoral immune function. We review pertinent history, pathology, and biochemistry of sarcoidosis and reconcile the common finding of cutaneous anergy with the presence of a hyperactive immune system. A hypothetical model of antigen-driven granuloma formation is discussed, citing relevant studies from blood, bronchoalveolar lavage, and in vitro-cultured intact sarcoidal skin granulomas. The etiology of sarcoidosis is considered, and we focus on the Kveim-Siltzbach skin test as an in vivo model for elucidation of the immune mechanisms of sarcoid granuloma formation, as well as a model for study of the sarcoid granulomagenic factor. We have adapted this skin test model to study the granulomagenicity of sarcoid autologous bronchoalveolar lavage and peripheral blood cells and demonstrate that early after onset of disease symptoms, bronchoalveolar lavage macrophages and peripheral blood monocytes are granulomagenic. This method extends our understanding of the source of the sarcoid granulomagenic factor and offers a model for tracking the agent as its identity is unraveled.

Entities:  

Year:  1996        PMID: 8812681     DOI: 10.1006/meth.1996.0033

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  3 in total

1.  β-glucan in the lymph nodes in sarcoidosis and in Kveim-Siltzbach test reagent.

Authors:  Marjeta Terčelj; Barbara Salobir; Ragnar Rylander
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

2.  Development of a T7 Phage Display Library to Detect Sarcoidosis and Tuberculosis by a Panel of Novel Antigens.

Authors:  Harvinder Talwar; Rita Rosati; Jia Li; Dana Kissner; Samiran Ghosh; Félix Fernández -Madrid; Lobelia Samavati
Journal:  EBioMedicine       Date:  2015-04-01       Impact factor: 8.143

3.  Autoantibodies against cytoskeletons and lysosomal trafficking discriminate sarcoidosis from healthy controls, tuberculosis and lung cancers.

Authors:  Samer Najeeb Hanoudi; Harvinder Talwar; Sorin Draghici; Lobelia Samavati
Journal:  Mol Biomed       Date:  2022-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.